Companies / SpyGlass Pharma, Inc.

SpyGlass Pharma, Inc.

Nasdaq: SGPSPGCIK 1778922IRVINE, CA

Financials

Revenue—

Net income$-39.87M

Total debt—

Cash$223.14M

Diluted EPS$-17.98

Shares outstanding33.4M

Ownership

33.4M shares outstanding · as of Jul 29, 2026

Ownership

Insiders	50.56%	16,912,218
10%+ / strategic	196.63%	65,769,539
Institutions	6.17%	2,062,582
Public float	0.00%	0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 32

View all →

Insider	% of shares	Shares
Baskett Forest10% owner	22.10%	7,392,301
Behbahani AliDirector · 10% owner	22.10%	7,392,301
Chang Carmen10% owner	22.10%	7,392,301
Florence Anthony A. Jr.10% owner	22.10%	7,392,301
Makhzoumi Mohamad10% owner	22.10%	7,392,301
Sandell Scott D10% owner	22.10%	7,392,301
Walker Paul Edward10% owner	22.10%	7,392,301
Mathers Edward T10% owner	18.04%	6,035,038
New Enterprise Associates 17, L.P.10% owner	18.04%	6,035,038
Yang Rick10% owner	18.04%	6,035,038

Institutional holders 10

View all →

Holder	Value	% of shares
RA Capital Management, L.P.	$207.83M	23.98%
BlackRock, Inc.	$15.84M	2.13%
Deerfield Management Company, L.P.	$14.25M	1.64%
Millennium Management LLC	$12.15M	1.40%
Geode Capital Management, LLC	$3.28M	0.38%
State Street Corporation	$2.62M	0.35%
TD Asset Management Inc	$1.23M	0.14%
Marshall Wace, LLP	$760.4K	0.09%
Deutsche Bank AG	$244.0K	0.03%
Royal Bank of Canada	$2.0K	<0.01%

Activity

View all →

InsidersInstitutions

What insiders are doing in this stock (Form 4).

Date	Actor	Action	Security	Value	Shares Δ	Position after	Impact
Feb 9, 2026	RA Capital Management, L.P. Director	Buy	Common Stock	$55.07M	+3.4M +136.34%	5,966,439 17.84% of shares	high
Feb 9, 2026	New Enterprise Associates 17, L.P. 10% owner	Buy	Common Stock	$15.00M	+938K +18.39%	6,035,038 18.04% of shares	high
Feb 9, 2026	Behbahani Ali Director	Buy	Common Stock	$15.00M	+938K +18.39%	6,035,038 18.04% of shares	high
Feb 9, 2026	Florence Anthony A. Jr. 10% owner	Buy	Common Stock	$15.00M	+938K +18.39%	6,035,038 18.04% of shares	high
Feb 9, 2026	Baskett Forest 10% owner	Buy	Common Stock	$15.00M	+938K +18.39%	6,035,038 18.04% of shares	high
Feb 9, 2026	Yang Rick 10% owner	Buy	Common Stock	$15.00M	+938K +18.39%	6,035,038 18.04% of shares	high
Feb 9, 2026	Makhzoumi Mohamad 10% owner	Buy	Common Stock	$15.00M	+938K +18.39%	6,035,038 18.04% of shares	high
Feb 9, 2026	Sandell Scott D 10% owner	Buy	Common Stock	$15.00M	+938K +18.39%	6,035,038 18.04% of shares	high

5%+ ownership events

Schedule 13D / 13G

Filer	Stance	% of class	Shares	Date
Samsara BioCapital, L.P.	Passive13G	—	—	—
Sands Capital Life Sciences Pulse Fund III (DE), L.P.	Passive13G	—	—	—

Securities

via CUSIP / OpenFIGI

Symbol	Type	Market	CUSIP	FIGI
SGP	Common Stock	Equity	85220G109	BBG01HDDMDS5